The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

CDC20 is a novel potential therapeutic target in NF1-mutant melanoma.

Douglas M.  Donnelly

No Relationships to Disclose

Keith M.  Giles

No Relationships to Disclose

Eleazar  Vega-Saenz de Miera

No Relationships to Disclose

Rebecca  Betensky

No Relationships to Disclose

Carolyn  Winskill

No Relationships to Disclose

Yu hsin  Yeh

No Relationships to Disclose

Iman  Osman

Employment - Dracen (I)

Leadership - Dracen (I)

George  Jour

Stock and Other Ownership Interests  - Calithera Biosciences; Celldex; La Jolla Pharma

Honoraria - Bristol-Myers Squibb

Consulting or Advisory Role - Bristol-Myers Squibb